Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

JBIO FY 2020 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

JBIOJade Biosciences, Inc.

$491M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,000

Operating Income

-$9M

Net Income

-$10M

EPS (Diluted)

$-14.00

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$5M

Total Liabilities

$2M

Stockholders' Equity

$3M

Cash & Equivalents

$5M

← FY 2021 All Quarters